Skip to main
DBD

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is projected to maintain its earnings growth through 2026/2027 thanks to strong execution, cost control measures, and visibility into margins. The company's well-stocked balance sheet allows for future investments and buybacks, in addition to its expansion into the U.S. market and partnerships with major retailers. With a positive outlook in North America, Europe, and Asia, DBD is recommended as a BUY with a strong financial standing and potential for further growth.

Bears say

Diebold Nixdorf is facing multiple risks such as potential tariff-related costs, disruptions in operations due to the COVID-19 pandemic and supply chain challenges, lower than expected activity in upgrade and replacement projects, and volatility in foreign currencies. The company also has low liquidity and high ownership concentration, with majority control in the hands of debtholders. While the company is expected to see sequential growth in the remainder of 2026, its current valuation and financials may not support a positive outlook.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $100, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $100, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.